During the past 12 months, Zoetis's average EBITDA Per Share Growth Rate was 11.60% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 12.50% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 12.10% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 16.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Zoetis was 677.80% per year. The lowest was -2.80% per year. And the median was 16.50% per year.
Competitive Comparison of Zoetis's 3-Year EBITDA Growth Rate
For the Drug Manufacturers - Specialty & Generic subindustry, Zoetis's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zoetis's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zoetis's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Zoetis's 3-Year EBITDA Growth Rate falls into.
Zoetis 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Zoetis 3-Year EBITDA Growth Rate Related Terms
Thank you for viewing the detailed overview of Zoetis's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZTS has been successfully added to your